Previous serological data have demonstrated cross-reactive antigens between two pathogenic species of mycoplasmas, M. pneumoniae and M. genitalium. Preliminary analysis of sera and monoclonal antibodies (MAbs) to protein antigens of these species showed an immunodominance of adhesin P1 (165 kilodaltons [kDa]) of M. pneumoniae in mice and hamsters and a 140-kDa protein of M. genitalium in mice and experimentally infected chimpanzees. To further characterize these two proteins, we assayed multiple anti-Pl and anti-140-kDa protein MAbs by enzyme-linked immunosorbent assay, immunoblot, and radioimmunoprecipitation techniques. The 140-kDa M. genitalium protein was shown to be surface accessible and insensitive to levels of trypsin which readily degrade protein P1. Peptide mapping was used to identify a unique class of MAbs which bound a cross-reactive molecule common to both the major adhesin protein P1 of M. pneumoniae and the 140-kDa protein of M. genitalium. MAbs generated against both M. pneumoniae and M. genitalium which were reactive with this determinant blocked M. pneumoniae attachment to chicken erythrocytes.
.02% bromophenol blue), and the samples were boiled for 3 min. Samples were then microcentrifuged for 5 min to pellet insoluble proteins. Solubilized mycoplasmas were then analyzed by preparative 7.5% SDS-polyacrylamide gel electrophoresis (PAGE) (14) . To determine where the proteins migrated, we stained a small longitudinal section of each gel with Coomassie brilliant blue (Sigma Chemical Co., St.
Louis, Mo.), and the unstained protein bands corresponding to the 165-kDa protein of M. pneumoniae and the 140-kDa protein of M. genitalium were then sliced, macerated, and gently shaken in H20 for 48 to 60 h at 4°C. The suspension was centrifuged at 17 ,000 x g for 20 min to pellet acrylamide fragments. Supernatants were lyophilized and reconstituted in coating buffer (26) at a final concentration of 40 ng/ml, and 75 RI was placed in each well of Immulon II microtiter plates (Dynatech) . Protein concentrations of the gel bands were determined by readings on a LKB Bromma 2202 ultrascan laser densitometer and 3390A Hewlett-Packard integrator.
Before use, antigen-coated wells were blocked with PBS supplemented with 1% bovine serum albumin (PBS-BSA; Sigma). The ELISA procedure has been described previously (19, 26) .
Competition ELISA. Competitive ELISAs were performed with alkaline phosphatase (bovine intestine type VII-T; Sigma)-labeled antibodies. Column-purified ascites of anti-P1 MAbs H5.2G4, H13.6E7, H10.8E8, and H12.5B8 were labeled according to the procedure of Voller et al. (26) .
Whole M. pneumoniae-coated microELISA wells were blocked with PBS-BSA. Unlabeled MAb was diluted in PBS-BSA and added to the antigen-coated wells 5 min before the addition of alkaline phosphatase-labeled MAb. Wells were then incubated for 2 h at 37°C before three washes with PBS and two with H20 followed by the addition of the p-nitrophenol phosphatase substrate.
Immunoglobulin isotyping of MAbs. MAbs were isotyped by ELISA as previously described (19) .
MAb purification. MAbs were purified by passage through a protein A-Sepharose CL4B column (Pharmacia Fine Chemicals, Piscataway, N.J.) (20 (5) . Briefly, M. pneumoniae was electrophoresed on 4% SDS-PAGE gels. The gels were stained with Coomassie brilliant blue, and then the P1 band was excised and equilibrated in buffer (0.125 M Tris [pH 6.8], 0.1% SDS, 1 mM EDTA) for 30 min. P1-containing gel fragments were then loaded onto 10% SDS-PAGE gels, and various concentrations of trypsin in a 20% glycerol solution were added. Samples were electrophoresed into the stacking gel and incubated for 90 min before continued electrophoresis through the separating gel. Gel proteins were then transferred to nitrocellulose membranes for immunoblotting.
Immunoprecipitation-immunoblot assays were performed with M. pneumoniae and M. genitalium solubilized in TDSET (10 mM Tris [pH 7.8], 0.2% sodium deoxycholate, 0.1% SDS, 10 mM tetrasodium EDTA, 1% Triton X-100) containing 1 mM phenylmethylsulfonyl fluoride. Mycoplasma preparations were processed by procedures previously described for the soluble-antigen radioimmunoprecipitation (RIP) assay (1 Immunofluorescence. Mycoplasmas were grown on 12-mm glass cover slips in their respective growth media. After 48 h, the medium was aspirated, and the cover slips were washed three times with PBS. Glass-attached mycoplasmas were then incubated for 2 h at 37°C in 1 ml of PBS-BSA to block nonspecific binding sites. Column-purified MAbs were diluted to 50 ,ug/ml in PBS-BSA and added to the cover slips. After a 2-h incubation at 37°C, cover slips were washed as before and incubated for 1 h at 37°C with a 1:50 dilution (in PBS-BSA) of rhodamine-labeled goat anti-mouse immunoglobulin (Hyclone). Cover slips were then washed and examined with a Leitz Ortholux II fluorescence microscope.
Chemicals. All enzymes and enzyme inhibitors were ob- the anti-140-kDa protein MAbs which were tested bound with the same intensity. Some appeared to bind weakly (Fig.  2B) or not at all, implying that the epitope which they recognized was oriented in such a manner as to sterically hinder binding or was not fully accessible. As a known positive control, MAbs to the P1 adhesin were incubated with M. pneumoniae (Fig. 2C) . Figure 2D demonstrates the lack of binding by an anti-140-kDa protein MAb to M.
pneumoniae.
Previous studies have demonstrated that protein P1 of M. pneumoniae is highly trypsin sensitive (2). When M. genitalium was exposed to various concentrations of trypsin, the intensity of the 140-kDa protein band was unaltered ( Fig. 3A and B) . Two small bands just below the 140-kDa protein were bound by the anti-140-kDa protein MAb (Fig.  3B ), yet these bands were not present when polyclonal antiserum was used (Fig. 3A) . Even at concentrations of trypsin which were previously shown to digest protein P1 readily and which clearly digested several other M. genitalium proteins, the 140-kDa protein was unaffected.
To further examine the protease sensitivity of the 140-kDa protein, we exposed M. genitalium to several enzymes at 5, 50, and 250 ,ug/500 ,g of mycoplasmas. Digestion was performed at 37°C for 30 min. Papainase at 50 and 250 ,ug tained from Sigma. The following enzymes were used: trypsin (EC 3.4.21.4, from bovine pancreas) type III; papainase (EC 3.4.22.2, from papaya latex) type IV; alphachymotrypsin (from bovine pancreas) type VII; Streptomyces griseus protease type XIV. The following inhibitors were used: trypsin inhibitor (from turkey egg white) type II-T; L-1-tosylamide-2-phenyl-ethylchloromethyl ketone; N-a-ptosyl-L-lysine chloromethyl ketone; and phenylmethylsulfonyl fluoride.
RESULTS
Immunodominance of 140-kDa protein of M. genitalium. Previous studies demonstrated the immunodominance of protein P1 of M. pneumoniae in human covalescent and hamster sera (15) . In multiple mouse hybridoma fusions with M. pneumoniae as the antigen, we showed that the majority of the resulting MAbs were specific for protein P1 (20) . Similarly, when MAbs binding to air-dried M. genitalium in the ELISA were analyzed by immunoblot or RIP, 52 of 126 antibodies were reactive. Of these, 23 hybridomas secreted MAbs which bound specifically to the 140-kDa protein. The remaining 29 clones secreted MAbs to a variety of other proteins with no more than four antibodies showing identical binding patterns. Clearly, the 140-kDa protein was highly immunogenic in mice immunized with M. genitalium. It was of interest to examine sera of experimentally infected chimpanzees to determine whether the 140-kDa protein would be immunogenic in a primate species (24) . Postinfection chimpanzee sera reacted strongly with the 140-kDa protein (Fig.  1) . These data encouraged further analysis of the surface accessibility and protease sensitivity of this immunodominant 140-kDa protein.
Characterization of 140-kDa protein of M. genitalium. To determine whether the 140-kDa protein of M. genitalium was expressed on the mycoplasma surface, M. genitalium was incubated with anti-140-kDa protein MAbs followed with rhodamine-conjugated anti-mouse immunoglobulin and examined for immunofluorescence. The 140-kDa protein is clearly surface accessible for binding by MAb H23.17H7 (anti-140-kDa protein) (Fig. 2A) . Interestingly, not all 13 of (Fig. 4, lanes G and H) classes based on their immunoblot profiles against trypsindigested protein P1. Figure 5 presents the profiles of each MAb class. Undigested protein P1 was bound by all three classes of MAbs (Fig. 5A) demonstrating that the three distinct classes of anti-Pl MAbs bound to different epitopes on the P1 molecule.
A class of MAbs to protein P1 of M. pneumoniae binds specifically to the 140-kDa protein of M. genitalium. Once classified, representative anti-Pl MAbs from the three classes were used to determine whether protein P1 and the 140-kDa protein were antigenically related. As anticipated from previous experiments (3), none of the MAbs in any of the three classes of anti-Pl MAbs precipitated a crossreactive protein of M. genitalium when analyzed by RIP. However, when these same antibodies were reacted by immunoblot methodology, one of the classes bound to a 140-kDa protein of M. genitalium (Fig. 6) . None of the antibodies in the other two classes of anti-Pl antibodies reacted by immunoblot with M. genitalium.
MAbs to 140-kDa protein of M. genitalium identify a cross-reactive epitope of M. pneumoniae. Identification of a class of anti-Pl MAbs which bound the 140-kDa protein of M. genitalium provided the rationale for examining anti-M. genitalium (140-kDa protein) MAbs for cross-reactivity with M. pneumoniae protein P1. When screened by immunoblot, a group of anti-140-kDa protein MAbs reacted with protein P1 (data not shown). None of the anti-140 antibody preparations bound protein P1 when assayed by RIP. To understand this discrepancy between immunoblot and RIP results, we performed a series of immunoprecipitationimmunoblot experiments using column-purified anti-140-kDa protein and anti-Pl MAbs. MAbs were reacted with unlabeled TDSET-solubilized mycoplasmas in a manner similar to the soluble-antigen RIP (1), and the antigen-antibody complex was precipitated with protein A-bearing S. aureus. Pellets and supernatants were then electrophoresed and blotted onto nitrocellulose for probing with the same antibody used in the precipitation part of the assay or an alternate MAb.
MAbs were able to precipitate only those proteins against which they were generated (i.e., homologous immunogens) (Fig. 7) . Anti-Pi MAb precipitated only protein P1, reflected by the presence of P1 in the antigen-antibody-S. aureus pellet (Fig. 7a, lane A) , and anti-M. genitalium 140-kDa protein MAb precipitated only the 140-kDa protein (Fig. 7b,  lane A) . These same antibodies were unable to precipitate the cross-reactive protein in the heterologous antigen preparation as indicated by the absence of antigen in the antibody-S. aureus pellets (Fig. 7c, lane A, and d, lane A) . It appeared that the MAbs were only able to bind to the cross-reactive heterologous antigen when the antigen was presented on a fixed matrix, such as nitrocellulose (Fig. 7c,  lane B, and d, systems. Initial antigen titrations demonstrated that the optimal antigen concentration for air-dried whole mycoplasmas was 2 jig of protein per well. Additional antigen titrations were performed with various dilutions of SDS-PAGE-eluted proteins (P1 and 140 kDa). Optimal binding occurred at a concentration of approximately 3 to 5 ng per well. Using these antigen concentrations, we screened a total of 12 anti-140-kDa protein and three anti-Pl MAbs by ELISA at antibody concentrations of 0.001 to 5.00 jig per microtiter well. ELISAs were performed with both M. pneumoniae and M. genitalium air-dried whole antigen preparations and gel-eluted protein P1 and 140-kDa proteins. Care was taken to coordinate the timing of the assays so that each MAb was tested simultaneously on the four antigens, thereby eliminating test variability which might arise from sequential assays. Figures 8A, B , and C are representative of the binding curves. In Fig. 8A and B, MAbs H13.6E7
(anti-Pl) and H23.1F11 (anti-140-kDa protein) bound to the homologous antigen preparations with optical density values up to 1,000-fold greater than that obtained with the heterologous antigen. This was most clearly observed in the geleluted preparations. Interestingly, at high antibody concentrations (>1 ,ug per well), 3 of the 12 anti-140-kDa protein MAbs were shown to bind strongly to the heterologous whole M. pneumoniae antigen preparation (Fig. 8C) . Nonspecific binding was not responsible for this observation since none of the MAbs (even at 10 to 50 ,ug per well) bound to other mycoplasma species (M. salivarium, M. orale, M. hominis) or A. laidlawii (data not shown).
Anti-140-kDa protein MAbs block attachment of M. pneumoniae to chicken RBCs. We previously demonstrated that MAbs to proteins of M. pneumoniae block attachment of mycoplasmas to chicken RBCs (20) . The significance of the binding curve shown in Fig. 8C was apparent when it was protein) to M. pneumoniae was observed by immunofluorescence, which reaffirmed the attachment data in Table 2 .
DISCUSSION
In this paper we used MAbs to characterize a 140-kDa surface-accessible protein of M. genitalium which, in contrast to M. pneumoniae protein P1, was determined to be insensitive to trypsin digestion. The surface location of this protein was documented by a variety of techniques including immunofluorescence (Fig. 1) , whole-cell ELISA (Fig. 8) , and accessibility of the protein to papain and protease digestion (Fig. 4) . The relationship between the M. pneumoniae adhesin P1 and the 140-kDa protein of M. genitalium was assessed by using three classes of anti-Pi MAbs which were distinguished by their immunoblot patterns with proteolytically digested P1. Partial enzymatic proteolysis of proteins is a frequently used method for mapping peptides (5) , and P1 is an ideal protein for mapping since it is easily digested by trypsin and produces a highly reproducible pattern (2) . One of the resulting classes of anti-Pl MAbs appeared to bind a cross-reactive antigen located on both the P1 and 140-kDa proteins.
Similarities between P1 and the 140-kDa protein such as surface location, immunodominance in experimentally infected animals, and the shared cross-reactivity of an epitope(s) on these two molecules led us to propose that the 140-kDa protein of M. genitalium might be functionally active in cytadherence. This hypothesis was supported by immunoprecipitation-immunoblot studies and attachment data which showed that one group of the anti-140-kDa protein MAbs identified a unique determinant which was cross-reactive with protein P1 and blocked attachment of M. pneumoniae to RBCs. Unfortunately, technical difficulties with M. genitalium prevented us from performing reproducible assays to determine whether these same MAbs inhibit M. genitalium attachment to RBCs.
Data presented help to explain a discrepancy between immunoblot and RIP results. The RIP required high-affinity antibodies to precipitate antigen-antibody-S. aureus protein A complexes. Antibody affinity was not as critical a factor when the antigens were presented in a manner which required simple binding (i.e., on a solid matrix such as an ELISA or immunoblot) as opposed to precipitation. Yet even in the solid matrix binding assays, it was necessary for low-affinity antibodies to be at relatively high protein concentrations for binding to occur.
The usefulness of MAbs for molecular analysis of microorganisms should not be underestimated; however, our studies underscore both the advantages and disadvantages associated with these immunologic probes. Their ability to distinguish unique epitopes enabled us to demonstrate at least one cross-reactive determinant among two immunodominant proteins that may have functional similarities in M. pneumoniae and M. genitalium. Our data also demonstrate that an inherent characteristic of MAbs is their variable affinity, and multiple techniques are necessary to ensure proper interpretation of experimental results.
